NEW YORK (360Dx) – Accelerate Diagnostics said after the close of the market on Tuesday that its third quarter revenues grew 63 percent year over year.

For the three months ended Sept. 30, the Tucson, Arizona-based firm posted revenues of $1.35 million, up from $828,000 in the prior-year, but well short of the consensus Wall Street estimate of $2.95 million. In early morning trading on the Nasdaq on Wednesday, Accelerate Dx's shares tumbled 17 percent to $13.54.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.